We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Benign tumors and pseudotumors of the liver.
Applied Pathology 1988
The pathologic and clinical aspects of benign tumors and pseudotumors of the liver are reviewed. They are classified according to the tissue of organ into epithelial (further subclassified into tumors of hepatocellular and cholangiocellular origin), mesenchymal or mixed derivation, and a miscellaneous group. Some of the tumors and pseudotumors, e.g. bile duct adenoma, small focal nodular hyperplasias and cavernous hemangiomas, and focal fatty change, are of no clinical significance. Others, such as nodular regenerative hyperplasia, hepatocellular adenoma and giant hemangioma, can be manifested by portal hypertension, hemoperitoneum or a hemorrhagic diathesis respectively. Cognizance of the histopathologic criteria for diagnosis, the radiologic features and the varied clinical manifestations are essential for management. The malignant potential of some of the benign tumors is briefly touched upon.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app